Although an anti-Trop-2 IgG-SN-38 conjugate was verified by Cardillo et al. to exert an antitumor effect [38], the use of the IgG antibody could not optimally recognize tumor marker since the existence of Fc fragments. Here, TACSTD2 is linked to neoplasm.